Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Twist Bioscience Corp

TWST
Current price
36.80 USD -1.57 USD (-4.09%)
Last closed 36.99 USD
ISIN US90184D1000
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 2 293 585 664 USD
Yield for 12 month +24.96 %
1Y
3Y
5Y
10Y
15Y
TWST
21.11.2021 - 28.11.2021

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California. Address: 681 Gateway Boulevard, South San Francisco, CA, United States, 94080

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

50.74 USD

P/E ratio

Dividend Yield

Current Year

+312 974 000 USD

Last Year

+245 109 000 USD

Current Quarter

+88 713 000 USD

Last Quarter

+84 710 000 USD

Current Year

+133 349 000 USD

Last Year

+89 729 000 USD

Current Quarter

+42 840 000 USD

Last Quarter

+38 233 000 USD

Key Figures TWST

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -136 527 008 USD
Operating Margin TTM -39.05 %
Price to Earnings
Return On Assets TTM -15.24 %
PEG Ratio
Return On Equity TTM -37.73 %
Wall Street Target Price 50.74 USD
Revenue TTM 330 188 992 USD
Book Value 7.65 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 24.10 %
Dividend Yield
Gross Profit TTM 147 227 008 USD
Earnings per share -3.38 USD
Diluted Eps TTM -3.38 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin -59.76 %

Dividend Analytics TWST

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History TWST

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation TWST

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 6.38
Price Sales TTM 6.95
Enterprise Value EBITDA -35.26
Price Book MRQ 5.03

Financials TWST

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TWST

For 52 weeks

27.96 USD 60.90 USD
50 Day MA 41.39 USD
Shares Short Prior Month 8 830 123
200 Day MA 45.42 USD
Short Ratio 8.43
Shares Short 9 592 757
Short Percent 18.17 %